PY2269577A - Método para tratar endometriosis y proporcionar una anticoncepción eficaz - Google Patents

Método para tratar endometriosis y proporcionar una anticoncepción eficaz

Info

Publication number
PY2269577A
PY2269577A PY202202269577A PY2269577A PY2269577A PY 2269577 A PY2269577 A PY 2269577A PY 202202269577 A PY202202269577 A PY 202202269577A PY 2269577 A PY2269577 A PY 2269577A PY 2269577 A PY2269577 A PY 2269577A
Authority
PY
Paraguay
Prior art keywords
drospirenone
treating endometriosis
providing effective
effective contraception
endometriosis
Prior art date
Application number
PY202202269577A
Other languages
English (en)
Spanish (es)
Inventor
Enrico Colli
Salustino Pérez
Original Assignee
Chemo Res S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Res S L filed Critical Chemo Res S L
Publication of PY2269577A publication Critical patent/PY2269577A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PY202202269577A 2021-08-12 2022-08-11 Método para tratar endometriosis y proporcionar una anticoncepción eficaz PY2269577A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP21382757.9A EP4134082A1 (de) 2021-08-12 2021-08-12 Verfahren zur behandlung von endometriose und zur bereitstellung einer wirksamen empfängnisverhütung

Publications (1)

Publication Number Publication Date
PY2269577A true PY2269577A (es) 2023-03-22

Family

ID=77358188

Family Applications (1)

Application Number Title Priority Date Filing Date
PY202202269577A PY2269577A (es) 2021-08-12 2022-08-11 Método para tratar endometriosis y proporcionar una anticoncepción eficaz

Country Status (22)

Country Link
US (4) US20240350515A1 (de)
EP (2) EP4134082A1 (de)
JP (1) JP7850799B2 (de)
KR (1) KR20240047421A (de)
CN (1) CN118076358A (de)
AR (1) AR126766A1 (de)
AU (2) AU2022327756C1 (de)
CA (1) CA3228483A1 (de)
CL (1) CL2024000418A1 (de)
CO (1) CO2024001947A2 (de)
CR (1) CR20240100A (de)
DO (1) DOP2024000021A (de)
EC (1) ECSP24016885A (de)
IL (1) IL310634A (de)
JO (1) JOP20240026A1 (de)
MX (1) MX2024001873A (de)
PE (1) PE20240811A1 (de)
PY (1) PY2269577A (de)
TW (1) TW202320801A (de)
UY (1) UY39895A (de)
WO (1) WO2023017109A1 (de)
ZA (1) ZA202401500B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4637781A1 (de) * 2023-02-23 2025-10-29 Estetra SRL Zusammensetzung mit estetrol und drospirenon zur verwendung bei der linderung und behandlung von schmerzen
CN121731275A (zh) * 2026-03-02 2026-03-27 杭州市妇产科医院 三乙酸甘油酯在制备预防或治疗不孕症药物中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (de) 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE19633685C1 (de) 1996-08-12 1997-10-09 Schering Ag Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
CN1270521A (zh) 1997-09-12 2000-10-18 美国家用产品公司 第一阶段包含孕激素/雌激素并且第二阶段包含孕激素的口服避孕制剂
ITMI20042338A1 (it) 2004-12-06 2005-03-06 Ind Chimica Srl Processo per la preparazione di drospirenone
US10849857B2 (en) * 2010-07-28 2020-12-01 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
AR081670A1 (es) 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
DK3313408T3 (da) 2015-06-23 2024-01-29 Laboratorios Leon Farma Sa Drospirenon-baseret svangerskabsforebyggende middel til en kvindelig patient, som lider af overvægt
CA3178291A1 (en) * 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
JP2018083806A (ja) * 2016-11-11 2018-05-31 持田製薬株式会社 月経困難症治療用組成物

Also Published As

Publication number Publication date
AU2026200242A1 (en) 2026-01-29
CO2024001947A2 (es) 2024-03-07
CN118076358A (zh) 2024-05-24
AU2022327756B2 (en) 2025-10-23
KR20240047421A (ko) 2024-04-12
JP2024529084A (ja) 2024-08-01
US12478630B2 (en) 2025-11-25
CR20240100A (es) 2024-10-07
CA3228483A1 (en) 2024-02-07
ZA202401500B (en) 2024-10-30
AR126766A1 (es) 2023-11-08
WO2023017109A1 (en) 2023-02-16
US20260021116A1 (en) 2026-01-22
TW202320801A (zh) 2023-06-01
US20260021117A1 (en) 2026-01-22
EP4134082A1 (de) 2023-02-15
US20250108061A1 (en) 2025-04-03
AU2022327756C1 (en) 2026-02-19
JOP20240026A1 (ar) 2024-02-08
JP7850799B2 (ja) 2026-04-23
US20240350515A1 (en) 2024-10-24
DOP2024000021A (es) 2024-05-15
UY39895A (es) 2023-03-31
MX2024001873A (es) 2024-03-01
ECSP24016885A (es) 2024-04-30
IL310634A (en) 2024-04-01
PE20240811A1 (es) 2024-04-18
CL2024000418A1 (es) 2024-09-06
EP4384184A1 (de) 2024-06-19
AU2022327756A1 (en) 2024-03-14

Similar Documents

Publication Publication Date Title
CL2024000418A1 (es) Método para tratar la endometriosis y proporcionar una anticoncepción eficaz
PE20190739A1 (es) Procedimiento de tratamiento de dismenorrea y dolor menstrual
PE20211588A1 (es) Compuestos y sus usos para aliviar sintomas asociados a la menopausia
ES2693085T1 (es) Uso de estriol en bajas dosis
CA2468748A1 (en) Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
GT201200281A (es) Formas de dosificación sólidas orales con dosis muy bajas para la hrt
AR057060A1 (es) Composiciones de tanaproget que contienen etinil estradiol
EA200600964A1 (ru) Фармацевтический препарат для непрерывного гормонального лечения в течение периода времени более длительного, чем 21-28 дней, включающий две композиции эстрогена и/или прогестина
CO2021000174A2 (es) Composiciones tópicas para el alivio del dolor
PE20040068A1 (es) Decanoato, undecanoato y dodecanoato de etonogestrel
AR049112A1 (es) Composiciones, metodos y kit, para el tratamiento de trastorno disforico premenstrual
EE05259B1 (et) Antiprogestiinide kasutamine hormoons?ltuvate haiguste proflaktikaks ja raviks
CO2026000331A2 (es) Inhibidores de tyk2 y composiciones y métodos de estos
MX2024009584A (es) Metodos anticonceptivos con efectos de sangrado programado.
MX2021011246A (es) Composicion de microbiota fecal viva estable a largo plazo.
AR043013A1 (es) Composicion farmaceutica destinada al tratamiento de la endometriosis
MX2023001301A (es) Uso antiviral de liraglutida y gefitinib.
AR120976A1 (es) Sistema para proporcionar un control de la natalidad
HRP20090256T1 (en) Use of estradiolvalerate and dienogest for oral treatment of dysfunctional uterine bleeding in a contraceptive method
CO2023002874A2 (es) Nueva composición de anticonceptivo oral de liberación modificada
AR132900A1 (es) Anticuerpos ampliamente neutralizantes dirigidos al sitio de unión de cd4 en la envoltura del vih
ECSP993091A (es) Regimen anticonceptivo del tipo "solo progestageno" que permite un buen control del ciclo y eficacia anticonceptiva, donde se suministra el progestageno en dos fases
CL2025002849A1 (es) Método y dispositivo para proporcionar una anticoncepción eficaz.
CY1112775T1 (el) Χρηση βαλεριανικης οιστραδιολης σε συνδυασμο με dienogest για την απο του στοματος θεραπεια της δυσλειτουργικης αιμορραγιας της μητρας σε ενοτητα με αντισυλληψη απο του στοματος
AR035633A1 (es) Drospirenona para terapia de reemplazo de hormonas